Literature DB >> 7822311

A new TEM beta-lactamase double mutant with broadened specificity reveals substrate-dependent functional interactions.

H Viadiu1, J Osuna, A L Fink, X Soberón.   

Abstract

Using a random combinatorial mutagenesis of TEM beta-lactamase, directed against residues potentially involved in substrate discrimination, followed by selection on third generation cephalosporins, we obtained the double mutant E104M/G238S. Additionally, by using cloning strategies and site-directed mutagenesis we constructed the individual single mutants and also the single modification E104K and the double mutant E104K/G238S, which broaden the specificity of clinically isolated TEM beta-lactamase variants. The kinetic characterization of the purified double mutant E104M/G238S and its single counterparts E104M and G238S was carried out. The single mutant E104M exhibited increased kcat values against all substrates tested. Km values remained similar to the values shown by the wild-type enzyme. The mutation at E104M was responsible for the increased hydrolysis rate against cefuroxime shown by the double mutant E104/G238S. The effect of mutation G238S varied more pronouncedly, depending on the substrate. In general, a lower Km was observed, but also a decreased kcat. The double mutant E104M/G238S exhibited a higher hydrolytic rate against cefotaxime compared with the corresponding single mutations. We observed nearly a 1000-fold greater kcat/Km for the double mutant than for the wild type. This improvement in catalysis was the consequence of increased kcat and decreased Km values. Computed contact interactions from modeling substrate complexes show reliable results only for benzylpenicillin. The modeling results with this substrate confirmed the observed enzyme activities for the different single and double mutants. Analysis of the apparent coupling energies, as calculated from the kinetic parameters of the single and double mutants, showed that the quantitative effect of a second mutation on a single mutant was either absent, additive, partially additive, or synergistic with respect to the first mutation, depending on the substrate analyzed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7822311

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Characterization of TEM-56, a novel beta-lactamase produced by a Klebsiella pneumoniae clinical isolate.

Authors:  C Neuwirth; R Labia; E Siebor; A Pechinot; S Madec; E B Chaibi; A Kazmierczak
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Roles of amino acids 161 to 179 in the PSE-4 omega loop in substrate specificity and in resistance to ceftazidime.

Authors:  C Therrien; F Sanschagrin; T Palzkill; R C Levesque
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

Review 3.  In vivo versus in vitro screening or selection for catalytic activity in enzymes and abzymes.

Authors:  J Fastrez
Journal:  Mol Biotechnol       Date:  1997-02       Impact factor: 2.695

4.  Characterization of a new TEM-derived beta-lactamase produced in a Serratia marcescens strain.

Authors:  M Perilli; A Felici; N Franceschini; A De Santis; L Pagani; F Luzzaro; A Oratore; G M Rossolini; J R Knox; G Amicosante
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

Review 5.  Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure.

Authors:  J R Knox
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

6.  Role of Asp104 in the SHV beta-lactamase.

Authors:  Christopher R Bethel; Andrea M Hujer; Kristine M Hujer; Jodi M Thomson; Mark W Ruszczycky; Vernon E Anderson; Marianne Pusztai-Carey; Magdalena Taracila; Marion S Helfand; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

7.  High tolerance to simultaneous active-site mutations in TEM-1 beta-lactamase: Distinct mutational paths provide more generalized beta-lactam recognition.

Authors:  Pierre-Yves De Wals; Nicolas Doucet; Joelle N Pelletier
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

Review 8.  Three decades of the class A beta-lactamase acyl-enzyme.

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

9.  A secondary drug resistance mutation of TEM-1 beta-lactamase that suppresses misfolding and aggregation.

Authors:  V Sideraki; W Huang; T Palzkill; H F Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

Review 10.  Structural and Mechanistic Basis for Extended-Spectrum Drug-Resistance Mutations in Altering the Specificity of TEM, CTX-M, and KPC β-lactamases.

Authors:  Timothy Palzkill
Journal:  Front Mol Biosci       Date:  2018-02-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.